Crohn?s Disease Therapeutics Market
Table of Contents
Global Crohn?s Disease Therapeutics Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Crohn?s Disease Therapeutics Market by Value
2.2.1 Global Crohn?s Disease Therapeutics Revenue by Type
2.2.2 Global Crohn?s Disease Therapeutics Market by Value
2.3 Global Crohn?s Disease Therapeutics Market by Sales
2.3.1 Global Crohn?s Disease Therapeutics Sales by Type
2.3.2 Global Crohn?s Disease Therapeutics Market by Sales
3. The Major Driver of Crohn?s Disease Therapeutics Industry
3.1 Historical & Forecast Global Crohn?s Disease Therapeutics Sales and Revenue (2018-2028)
3.2 Largest Application for Crohn?s Disease Therapeutics (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Crohn?s Disease Therapeutics Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Crohn?s Disease Therapeutics Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Crohn?s Disease Therapeutics Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Crohn?s Disease Therapeutics Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Crohn?s Disease Therapeutics Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Crohn?s Disease Therapeutics Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Crohn?s Disease Therapeutics Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Crohn?s Disease Therapeutics Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Crohn?s Disease Therapeutics Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Crohn?s Disease Therapeutics Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Crohn?s Disease Therapeutics Average Price Trend
13.1 Market Price for Each Type of Crohn?s Disease Therapeutics in US (2018-2022)
13.2 Market Price for Each Type of Crohn?s Disease Therapeutics in Europe (2018-2022)
13.3 Market Price for Each Type of Crohn?s Disease Therapeutics in China (2018-2022)
13.4 Market Price for Each Type of Crohn?s Disease Therapeutics in Japan (2018-2022)
13.5 Market Price for Each Type of Crohn?s Disease Therapeutics in India (2018-2022)
13.6 Market Price for Each Type of Crohn?s Disease Therapeutics in Korea (2018-2022)
13.7 Market Price for Each Type of Crohn?s Disease Therapeutics in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Crohn?s Disease Therapeutics in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Crohn?s Disease Therapeutics Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Crohn?s Disease Therapeutics
15. Crohn?s Disease Therapeutics Competitive Landscape
15.1 Johnson and Johnson Services Inc.
15.1.1 Johnson and Johnson Services Inc. Company Profiles
15.1.2 Johnson and Johnson Services Inc. Product Introduction
15.1.3 Johnson and Johnson Services Inc. Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Pfizer Inc.
15.2.1 Pfizer Inc. Company Profiles
15.2.2 Pfizer Inc. Product Introduction
15.2.3 Pfizer Inc. Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Allergan
15.3.1 Allergan Company Profiles
15.3.2 Allergan Product Introduction
15.3.3 Allergan Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 AbbVie Inc.
15.4.1 AbbVie Inc. Company Profiles
15.4.2 AbbVie Inc. Product Introduction
15.4.3 AbbVie Inc. Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Takeda Pharmaceutical Company Limited
15.5.1 Takeda Pharmaceutical Company Limited Company Profiles
15.5.2 Takeda Pharmaceutical Company Limited Product Introduction
15.5.3 Takeda Pharmaceutical Company Limited Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Celgene Corporation
15.6.1 Celgene Corporation Company Profiles
15.6.2 Celgene Corporation Product Introduction
15.6.3 Celgene Corporation Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Perrigo Company PLC
15.7.1 Perrigo Company PLC Company Profiles
15.7.2 Perrigo Company PLC Product Introduction
15.7.3 Perrigo Company PLC Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Ferring B.V.
15.8.1 Ferring B.V. Company Profiles
15.8.2 Ferring B.V. Product Introduction
15.8.3 Ferring B.V. Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Salix Pharmaceuticals
15.9.1 Salix Pharmaceuticals Company Profiles
15.9.2 Salix Pharmaceuticals Product Introduction
15.9.3 Salix Pharmaceuticals Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Gilead Sciences Inc.
15.10.1 Gilead Sciences Inc. Company Profiles
15.10.2 Gilead Sciences Inc. Product Introduction
15.10.3 Gilead Sciences Inc. Crohn?s Disease Therapeutics Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Genentech Inc.
15.12 UCB India Private Limited.
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Crohn?s Disease Therapeutics Industry (Volume)
Figure 2. Crohn?s Disease Therapeutics Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Crohn?s Disease Therapeutics Revenue in 2022
Figure 5. US Crohn?s Disease Therapeutics Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Crohn?s Disease Therapeutics Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Crohn?s Disease Therapeutics Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Crohn?s Disease Therapeutics Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Crohn?s Disease Therapeutics Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Crohn?s Disease Therapeutics Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Crohn?s Disease Therapeutics Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Crohn?s Disease Therapeutics Revenue, by Type (Million USD) (2018-2028)
Table 4. Crohn?s Disease Therapeutics Sales, by Type (K Unit) (2018-2028)
Table 5. Crohn?s Disease Therapeutics Sales (K Unit) by Application (2018-2028)
Table 6. Crohn?s Disease Therapeutics Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Crohn?s Disease Therapeutics Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Crohn?s Disease Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Crohn?s Disease Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Crohn?s Disease Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Crohn?s Disease Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Crohn?s Disease Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Crohn?s Disease Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Crohn?s Disease Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Crohn?s Disease Therapeutics in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Crohn?s Disease Therapeutics in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Crohn?s Disease Therapeutics in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Crohn?s Disease Therapeutics in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Crohn?s Disease Therapeutics in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Crohn?s Disease Therapeutics in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Crohn?s Disease Therapeutics in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Johnson and Johnson Services Inc. Profiles
Table 61. Johnson and Johnson Services Inc. Crohn?s Disease Therapeutics Product Introduction
Table 62. Johnson and Johnson Services Inc. Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Johnson and Johnson Services Inc. Strategic initiatives
Table 64. Pfizer Inc. Profiles
Table 65. Pfizer Inc. Crohn?s Disease Therapeutics Product Introduction
Table 66. Pfizer Inc. Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Pfizer Inc. Strategic initiatives
Table 68. Allergan Profiles
Table 69. Allergan Crohn?s Disease Therapeutics Product Introduction
Table 70. Allergan Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Allergan Strategic initiatives
Table 72. AbbVie Inc. Profiles
Table 73. AbbVie Inc. Crohn?s Disease Therapeutics Product Introduction
Table 74. AbbVie Inc. Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. AbbVie Inc. Strategic initiatives
Table 76. Takeda Pharmaceutical Company Limited Profiles
Table 77. Takeda Pharmaceutical Company Limited Crohn?s Disease Therapeutics Product Introduction
Table 78. Takeda Pharmaceutical Company Limited Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Takeda Pharmaceutical Company Limited Strategic initiatives
Table 80. Celgene Corporation Profiles
Table 81. Celgene Corporation Crohn?s Disease Therapeutics Product Introduction
Table 82. Celgene Corporation Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Celgene Corporation Strategic initiatives
Table 84. Perrigo Company PLC Profiles
Table 85. Perrigo Company PLC Crohn?s Disease Therapeutics Product Introduction
Table 86. Perrigo Company PLC Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Perrigo Company PLC Strategic initiatives
Table 88. Ferring B.V. Profiles
Table 89. Ferring B.V. Crohn?s Disease Therapeutics Product Introduction
Table 90. Ferring B.V. Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Ferring B.V. Strategic initiatives
Table 92. Salix Pharmaceuticals Profiles
Table 93. Salix Pharmaceuticals Crohn?s Disease Therapeutics Product Introduction
Table 94. Salix Pharmaceuticals Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Salix Pharmaceuticals Strategic initiatives
Table 97. Gilead Sciences Inc. Profiles
Table 98. Gilead Sciences Inc. Crohn?s Disease Therapeutics Product Introduction
Table 99. Gilead Sciences Inc. Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Gilead Sciences Inc. Strategic initiatives
Table 101. Genentech Inc. Profiles
Table 102. Genentech Inc. Crohn?s Disease Therapeutics Product Introduction
Table 103. Genentech Inc. Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Genentech Inc. Strategic initiatives
Table 105. UCB India Private Limited. Profiles
Table 106. UCB India Private Limited. Crohn?s Disease Therapeutics Product Introduction
Table 107. UCB India Private Limited. Crohn?s Disease Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. UCB India Private Limited. Strategic initiatives
Industry Market Size
